A new Alzheimer’s drug is on the market for the first time in almost 20 years.
- The Food and Drug Administration seemingly disregarded warnings from independent advisers and approved Biogen today.
- The FDA gave its approval based on study results showing it seemed “reasonably likely” to benefit Alzheimer’s patients.
- Opponents say the treatment hasn’t been shown to help slow the disease.
- If you could cure one disease, which one would you pick? Why?
Photo Credit: Getty Images